Question:

What are the possible consequences for applicable labs that fail to report data under PAMA?

Question:

What information is applicable in the private-payer claims data for (PAMA) reporting?

Question:

When do labs meet the definition of “applicable laboratory” under CLFS?

Question:

When are laboratories required to report private-payer data under PAMA?

Question:

What is the Centers for Medicare & Medicaid Service’s (CMS) current guidance for date of service (DOS) for molecular pathology test regarding an ADLT?

Question:

How does the Eliminating Kickbacks in Recovery Act (EKRA) define labs?

Question:

What penalties are included in the Eliminating Kickbacks in Recovery Act of (EKRA)?

Question:

What guidance does the Centers for Medicare & Medicaid Services provide for tests on live tissue date of service (DOS)?

Question:

How many new waived tests will be effective in July 2019?